Protagenic Therapeutics, Inc.\new Earnings Per Share (Basic)
Protagenic Therapeutics, Inc.\new (PTIX) reported Earnings Per Share (Basic) of -$0.53 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-19
- Protagenic Therapeutics, Inc.\new earnings per share, basic for the quarter ending 2026-06-30 was -$0.53.
- Protagenic Therapeutics, Inc.\new earnings per share, basic for the quarter ending 2026-03-31 was $2.69.
- Protagenic Therapeutics, Inc.\new earnings per share, basic for the quarter ending 2025-12-31 was $1.14.
- Protagenic Therapeutics, Inc.\new earnings per share, basic for the quarter ending 2025-09-30 was -$0.47.
- Protagenic Therapeutics, Inc.\new earnings per share, basic for fiscal 2026 was $0.59.
- Protagenic Therapeutics, Inc.\new earnings per share, basic for fiscal 2025 was -$0.67.
- Protagenic Therapeutics, Inc.\new earnings per share, basic for fiscal 2024 was -$1.13.
- Protagenic Therapeutics, Inc.\new earnings per share, basic for fiscal 2023 was -$1.15.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.53 10-Q · filed 2026-08-19 | $2.23 derived: net income ÷ weighted average shares · filed 2026-08-19 | $3.37 derived: net income ÷ weighted average shares · filed 2026-08-19 | $2.92 derived: net income ÷ weighted average shares · filed 2026-08-19 | |||
| 2026-03-31 | $2.69 derived: net income ÷ weighted average shares · filed 2026-08-14 | $3.82 derived: net income ÷ weighted average shares · filed 2026-08-14 | $3.40 derived: net income ÷ weighted average shares · filed 2026-08-14 | $0.59 10-K · filed 2026-08-14 | |||
| 2025-12-31 | $1.14 10-Q · filed 2026-03-09 | $0.71 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$1.50 10-Q · filed 2026-03-09 | -$2.58 derived: net income ÷ weighted average shares · filed 2026-08-19 | |||
| 2025-09-30 | -$0.47 10-Q · filed 2025-11-26 | -$2.16 10-Q · filed 2025-11-26 | -$3.64 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$2.87 derived: net income ÷ weighted average shares · filed 2026-08-19 | |||
| 2025-06-30 | -$1.37 10-Q · filed 2026-08-19 | -$3.08 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$2.29 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$2.11 derived: net income ÷ weighted average shares · filed 2026-08-19 | |||
| 2025-03-31 | -$2.75 10-Q · filed 2025-05-13 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$0.67 10-K · filed 2026-08-14 | |||
| 2024-12-31 | -$0.16 10-Q · filed 2026-03-09 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$0.33 10-Q · filed 2026-03-09 | -$1.13 10-K · filed 2025-03-31 | |||
| 2024-09-30 | -$0.11 10-Q · filed 2025-11-26 | -$0.14 10-Q · filed 2024-11-14 | -$0.17 10-Q · filed 2025-11-26 | -$0.89 10-Q · filed 2024-11-14 | -$1.11 derived: net income ÷ weighted average shares · filed 2026-03-09 | ||
| 2024-06-30 | -$0.06 10-QT · filed 2025-09-10 | -$0.36 10-Q · filed 2024-08-14 | -$0.75 10-Q · filed 2024-08-14 | -$1.11 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$1.42 derived: net income ÷ weighted average shares · filed 2026-03-09 | ||
| 2024-03-31 | -$5.44 10-Q · filed 2025-05-13 | -$0.39 10-Q · filed 2024-05-15 | -$1.44 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$1.59 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$1.80 derived: net income ÷ weighted average shares · filed 2025-05-13 | ||
| 2023-12-31 | -$0.38 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.70 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.98 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$1.15 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$0.32 10-Q · filed 2024-11-14 | -$0.60 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.77 10-Q · filed 2024-11-14 | -$0.91 derived: net income ÷ weighted average shares · filed 2024-11-14 | |||
| 2023-06-30 | -$0.28 10-Q · filed 2024-08-14 | -$0.45 10-Q · filed 2024-08-14 | -$0.58 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.80 derived: net income ÷ weighted average shares · filed 2024-11-14 | |||
| 2023-03-31 | -$0.17 10-Q · filed 2024-05-15 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.52 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.67 derived: net income ÷ weighted average shares · filed 2024-11-14 | |||
| 2022-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$0.35 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$0.51 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$0.82 10-K/A · filed 2024-05-14 | |||
| 2022-09-30 | -$0.21 10-Q · filed 2023-11-14 | -$0.05 10-Q · filed 2022-11-14 | -$0.37 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.68 10-Q · filed 2023-11-14 | -$0.17 10-Q · filed 2022-11-14 | $1.09 derived: net income ÷ weighted average shares · filed 2023-11-14 | |
| 2022-06-30 | -$0.15 10-Q · filed 2023-08-14 | -$0.04 10-Q · filed 2022-08-11 | -$0.47 10-Q · filed 2023-08-14 | -$0.12 10-Q · filed 2022-08-11 | $0.47 derived: net income ÷ weighted average shares · filed 2023-11-14 | $7.88 derived: net income ÷ weighted average shares · filed 2023-11-14 | |
| 2022-03-31 | -$0.32 10-Q · filed 2023-05-15 | -$0.08 10-Q · filed 2022-05-13 | $0.20 derived: net income ÷ weighted average shares · filed 2023-11-14 | $1.50 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$2.27 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||
| 2021-12-31 | $0.03 derived: net income ÷ weighted average shares · filed 2023-03-31 | $0.34 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$2.53 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$1.24 10-K · filed 2023-03-31 | |||
| 2021-09-30 | -$0.05 10-Q · filed 2022-11-14 | -$0.16 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.26 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | -$0.11 10-Q · filed 2022-08-11 | -$0.22 10-Q · filed 2022-08-11 | |||||
| 2021-03-31 | -$0.11 10-Q · filed 2022-05-13 | ||||||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-07-25 | $0.00 10-Q · filed 2015-05-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-07-25 | |||
| 2014-12-31 | $0.00 10-Q · filed 2015-02-06 | $0.00 10-Q · filed 2015-02-06 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-03-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-07-12 | |||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2015-11-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2015-11-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2015-11-13 | |||
| 2014-06-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2015-09-25 | -$0.00 derived: net income ÷ weighted average shares · filed 2015-09-25 | -$0.00 derived: net income ÷ weighted average shares · filed 2015-09-25 | $0.00 10-K · filed 2014-10-14 | |||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2015-05-11 | $0.00 10-Q · filed 2015-05-11 | ||||
| 2013-12-31 | $0.00 10-Q · filed 2015-02-06 | $0.00 10-Q · filed 2015-02-06 | |||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | ||||||
| 2011-09-30 | -$0.72 10-Q · filed 2011-11-14 | -$1.69 derived: net income ÷ weighted average shares · filed 2011-11-14 | -$2.25 10-Q · filed 2011-11-14 | ||||
| 2011-06-30 | -$0.97 10-Q/A · filed 2011-09-07 | -$1.53 10-Q/A · filed 2011-09-07 | |||||
| 2010-09-30 | -$0.70 10-Q · filed 2011-11-14 | -$1.56 derived: net income ÷ weighted average shares · filed 2011-11-14 | -$2.22 10-Q · filed 2011-11-14 | ||||
| 2010-06-30 | -$0.86 10-Q/A · filed 2011-09-07 | -$1.52 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |